ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Scope & Guideline

Elevating Research Standards in Biochemistry and Biophysics.

Introduction

Explore the comprehensive scope of ACTA BIOCHIMICA ET BIOPHYSICA SINICA through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore ACTA BIOCHIMICA ET BIOPHYSICA SINICA in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1672-9145
PublisherSCIENCE PRESS
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationACTA BIOCH BIOPH SIN / Acta Biochim. Biophys. Sin.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING 100009, PEOPLES R CHINA

Aims and Scopes

ACTA BIOCHIMICA ET BIOPHYSICA SINICA focuses on the biochemical and biophysical aspects of biological processes, offering insights into molecular mechanisms underlying various diseases and therapeutic approaches.
  1. Glycosylation and its Implications:
    The journal has a strong emphasis on the role of glycosylation in disease mechanisms, particularly in cancer and neurodegenerative diseases. This includes studies on glyco-signatures and post-translational modifications that influence cellular functions.
  2. Cancer Biology and Therapeutics:
    A significant portion of the research is dedicated to understanding cancer biology, including tumor microenvironments, resistance mechanisms, and potential therapeutic targets. The journal publishes studies on cellular signaling pathways involved in cancer progression.
  3. Immunology and Inflammation:
    The journal covers research related to immune responses in various contexts, including cancer immunotherapy, autoimmune diseases, and inflammatory responses. This includes studies on macrophage polarization and the role of immune cells in disease progression.
  4. Metabolism and Disease:
    Research on metabolic pathways and their implications in diseases such as diabetes, obesity, and cardiovascular diseases is prevalent. This includes studies on metabolic reprogramming in cancer and the impact of dietary components on health.
  5. Molecular Mechanisms and Target Identification:
    The journal emphasizes the molecular mechanisms of action for various compounds, including natural products and synthetic drugs, aiming to identify new therapeutic targets for disease management.
Recent publications in ACTA BIOCHIMICA ET BIOPHYSICA SINICA reveal several emerging themes that indicate a shift towards more innovative and relevant areas of research.
  1. Glycosylation as a Therapeutic Target:
    Research on glycosylation has surged, particularly in its role in cancer and immune responses. This includes studies that explore glycosylation patterns as potential biomarkers and therapeutic targets, highlighting its significance in personalized medicine.
  2. Metabolic Reprogramming in Cancer:
    There is a growing focus on the intersection of metabolism and cancer biology, with studies exploring how metabolic changes drive tumorigenesis and treatment resistance. This area is increasingly relevant as researchers seek to understand cancer metabolism for therapeutic interventions.
  3. Cellular Mechanotransduction:
    Emerging studies are focusing on how mechanical forces influence cellular behavior, particularly in cancer and tissue regeneration. This theme reflects an interdisciplinary approach combining biology, physics, and engineering to understand cellular responses.
  4. Role of Non-Coding RNAs:
    Research on non-coding RNAs, particularly in the context of cancer and metabolic diseases, is gaining momentum. These studies are exploring their roles in gene regulation and potential as therapeutic targets.
  5. Immunotherapy and Immune Modulation:
    There is a significant increase in research related to immunotherapy, particularly in relation to cancer treatment. This includes studies on immune checkpoint inhibitors, CAR-T cell therapies, and the modulation of immune responses to enhance therapeutic efficacy.

Declining or Waning

While ACTA BIOCHIMICA ET BIOPHYSICA SINICA maintains a broad focus, certain themes have shown a decline in prominence in recent publications, reflecting shifts in research interests.
  1. Traditional Medicinal Approaches:
    There has been a noticeable decrease in studies exclusively focused on traditional Chinese medicine compared to previous years. This may suggest a shift towards more modern, mechanistic studies that integrate traditional knowledge with contemporary scientific methods.
  2. Basic Biochemical Techniques:
    Research that primarily focuses on basic biochemical techniques without application to specific diseases or therapeutic contexts appears to be waning. There is a trend towards more applied research that connects biochemical findings with clinical relevance.
  3. Animal Models in Basic Research:
    The use of animal models for purely basic research has seen a decline, likely due to increasing emphasis on translational research and the need for more human-relevant models that can better predict clinical outcomes.

Similar Journals

Annual Review of Biochemistry

Illuminating the Path of Biochemical Research
Publisher: ANNUAL REVIEWSISSN: 0066-4154Frequency: 1 issue/year

Annual Review of Biochemistry is a premier publication in the field of biochemistry, renowned for its comprehensive and critical reviews that collate significant advancements and insights since its inception in 1946. Published by Annual Reviews in the United States, this journal maintains a prestigious position within the academic community, boasting a Q1 ranking in the biochemistry category for 2023, with an impressive Scopus rank of #4 out of 438, placing it in the top 1% of its field. With a commitment to excellence, it serves as an essential resource for researchers, professionals, and students striving to stay at the forefront of biochemical research. While the journal does not operate on an open-access model, it continues to provide key insights and knowledge that fuel innovation and discovery in the life sciences. As it converges research from various eras up to 2024, Annual Review of Biochemistry remains a vital contributor to the development of molecular biology and genetics, catering to the needs of a diverse readership keen on advancing their understanding and expertise in biochemistry.

CELLULAR SIGNALLING

Exploring the Intricacies of Cell Biology
Publisher: ELSEVIER SCIENCE INCISSN: 0898-6568Frequency: 12 issues/year

CELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.

FEBS Open Bio

Advancing the frontiers of biochemistry and molecular biology.
Publisher: WILEYISSN: 2211-5463Frequency: 1 issue/year

FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

Biochemistry and Cell Biology

Shaping the future of biochemistry and cell biology through shared insights.
Publisher: CANADIAN SCIENCE PUBLISHINGISSN: 0829-8211Frequency: 6 issues/year

Biochemistry and Cell Biology, published by Canadian Science Publishing, is a prestigious journal that has been instrumental in advancing the fields of biochemistry, molecular biology, and cell biology since its inception in 1986. With an impressive scope spanning innovative research findings to comprehensive reviews, this journal serves as a vital resource for researchers, professionals, and students alike. Currently positioned in the Q2 quartile in Biochemistry and Q3 quartiles in both Cell Biology and Molecular Biology, it reflects a robust contribution to scientific discourse, placing it among reputable publications in its field. The journal boasts notable rankings within the Scopus database, highlighting its impact and relevance, and continues to be a valuable platform for disseminating pivotal research. By providing access to a wide array of articles, the journal remains committed to fostering knowledge and collaboration in the scientific community.

Doklady Biochemistry and Biophysics

Fostering Scholarly Discourse in Biochemistry and Biophysics
Publisher: MAIK NAUKA/INTERPERIODICA/SPRINGERISSN: 1607-6729Frequency: 6 issues/year

Doklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Bridging Research and Innovation in Life Sciences
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1357-2725Frequency: 12 issues/year

The International Journal of Biochemistry & Cell Biology, published by Pergamon-Elsevier Science Ltd, stands as a pivotal resource in the fields of biochemistry and cell biology. With an ISSN of 1357-2725 and an E-ISSN of 1878-5875, this prestigious journal has been a key platform for disseminating cutting-edge research since its inception in 1995. The journal currently holds an impressive Q1 ranking in Biochemistry and a Q2 ranking in Cell Biology for the year 2023, reflecting its commitment to high-quality research and its influence within the scientific community. With a significant Scopus ranking of 94/438 in Biochemistry and 96/285 in Cell Biology, the journal plays a crucial role in advancing knowledge and fostering innovative approaches in these dynamic fields. Though it is not an open-access journal, the International Journal of Biochemistry & Cell Biology remains accessible to a wide audience, making it a vital resource for researchers, professionals, and students alike, who are eager to explore and contribute to the ongoing advancements in biochemistry and cell biology.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Exploring the Depths of Biochemical Research
Publisher: TAYLOR & FRANCIS LTDISSN: 1040-9238Frequency: 6 issues/year

Welcome to Critical Reviews in Biochemistry and Molecular Biology, a premier academic journal published by Taylor & Francis Ltd, dedicated to advancing the fields of biochemistry and molecular biology. With an impressive impact factor and a Q1 ranking in both Biochemistry and Molecular Biology for 2023, this journal serves as a vital resource for researchers, professionals, and students eager to engage with cutting-edge reviews and analyses that synthesize the latest developments in these dynamic areas of study. Since its inception in 1972, the journal has maintained a commitment to high-quality scholarship, providing a platform for critical discussions that accelerate the discovery and understanding of biochemical processes and molecular interactions. Although not open access, its robust editorial peer-review process ensures that published articles meet the highest standards of scientific rigor, making it a trusted source for the scientific community. As we continue to converge toward 2024, we invite you to explore the extensive array of topics and findings that have shaped contemporary biochemistry and molecular biology.

BMB Reports

Fostering Dialogue in Biochemical Innovation
Publisher: KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGYISSN: 1976-6696Frequency: 12 issues/year

BMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.

BIOSCIENCE REPORTS

Fostering Innovation in Biological Research
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Unveiling the complexities of molecular life.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0006-291XFrequency: 52 issues/year

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.